FDA Drug Recalls

Recalls / Brands / Namzaric

Namzaric

1 FDA drug recall involving brand “Namzaric.

DateClassProductFirm
2021-03-15Class IINamzaric (memantine HCl extended release and donepezil HCl) capsules 14 mg/10 mg per capsule 30 capsules Rx OnCardinal Health Inc.